Cargando…
Trimethylamine generation in patients receiving hemodialysis treated with l-carnitine
Autores principales: | Ozasa, Hisashi, Shimizu, Makiko, Koizumi, Ayano, Wakabayashi, Akari, Yamazaki, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377763/ https://www.ncbi.nlm.nih.gov/pubmed/25852904 http://dx.doi.org/10.1093/ckj/sfu045 |
Ejemplares similares
-
Effects of l-Carnitine Supplementation in Patients Receiving Hemodialysis or Peritoneal Dialysis
por: Kuwasawa-Iwasaki, Masako, et al.
Publicado: (2020) -
Marked elevation in plasma trimethylamine-N-oxide (TMAO) in patients with mitochondrial disorders treated with oral l-carnitine
por: Vallance, H.D., et al.
Publicado: (2018) -
Effects of intravenous l-carnitine on myocardial fatty acid imaging in hemodialysis patients: responders or non-responders to l-carnitine
por: Nishimura, Masato, et al.
Publicado: (2015) -
Plasma Trimethylamine-N-oxide following Cessation of L-carnitine Supplementation in Healthy Aged Women
por: Samulak, Joanna J., et al.
Publicado: (2019) -
The Association of Circulating L-Carnitine, γ-Butyrobetaine and Trimethylamine N-Oxide Levels with Gastric Cancer
por: Stonāns, Ilmārs, et al.
Publicado: (2023)